Skip to main content
Hospital Pharmacy logoLink to Hospital Pharmacy
letter
. 2025 Aug 27;61(1):15–19. doi: 10.1177/00185787251364488

The Clinical Utility and Stewardship Challenges of Time to Blood Culture Positivity

Ahmed S Elnoby, Radwa Nahla
PMCID: PMC12391036  PMID: 40894300

Introduction

Time-to-positivity (TTP) is the automated period elapsed from culture inoculation to the initial signal of bacterial growth. 1 The earliest clinical value of TTP was described for central line-associated bloodstream infection (CLABSI); ≥2 hours between central and peripheral culture growth, which is the best to diagnose CLABSI with high sensitivity and specificity. 2 Later, studies investigated the predictive value of TTP for bacteremia caused by different bacterial species and fungi, providing primarily positive results to help clinicians.3,4 There is still a notable controversy on disease severity, mortality, and the burden of bacteremia associated with TTP. Short TTP is associated with a higher initial bacterial burden and severe infections with a higher mortality risk in bacteremia.5,6 However, the extended TTP may be associated with a lower initial bacterial burden, slow-growing bacteria, and could be observed after antibiotic initiation. 5 Despite many previous studies indicating the utility of TTP as a diagnostic and prognostic index, several clinical and microbiological factors have the potential to affect the predicted outcome of TTP. However, measurement of TTP is supported by clinical practice guidelines to promote antimicrobial stewardship and optimization of antimicrobial therapy.7,8 The objective of this article was to demonstrate the clinical utility of TTP and to highlight the challenges of its implementation in antimicrobial stewardship.

Evidence Acquisition

A comprehensive search was conducted using electronic databases, including PubMed, Web of Science, and the Cochrane Library. A manual search was performed by scanning the references of eligible studies. The search was conducted in any language and spanned from October 2024. The search was conducted using Medical Subject Headings (MeSH), and index terms include time-to-positivity, blood culture, clinical outcomes, mortality, stewardship, and prognosis. We retrieved all observational, retrospective, and prospective studies discussing the impact of TTP on patient outcomes, stewardship de-escalation strategies, and the utility of TTP as a prognostic and diagnostic indicator.

We retrieved all records from the literature search and screened them for eligibility in relation to our purpose: the correlation between TTP and patient outcomes, as well as stewardship strategies. Out of 141 records, 28 studies investigated the predictive value and clinical utility of TTP. Figure 1 PRISMA flow diagram of study selection—summary of all relevant studies described in Table 1.

Figure 1.

This diagram is a PRISMA flow chart showing the steps for selecting studies for review, starting from identification through inclusion.

PRISMA flow diagram of study selection.

Table 1.

Summary of All Observational Studies Investigating the Correlation Between TTP, Patient Outcomes, and Stewardship De-escalation Strategies.

Year, author Study design Country Population (n) Study objective Bacteria Mean TTP hours Infection source Conclusion
2021, Oldberg K 9 Retrospective Sweden Adult (359) Determine clinical outcomes and factors affecting TTP with infective endocarditis Enterococcus faecalis 11.6 Infective endocarditis Short TTP (≤12 h) is associated with infective endocarditis and could be helpful to determine the need for ECHO. Also, no association was detected between TTP and mortality.
2014, Hsu MS 29 Retrospective Taiwan Adult (87) Determine the TTP of BCs and correlation with patient outcomes Staphylococcus aureus 1st: 12.6 2nd: 24.7 Multiple A ratio of 2nd/1st TTP of <1.5 is associated with poor outcome in persistent growth of Staphylococcus aureus.
2010, Kim J 30 Retrospective Canada Adult (684) Impact of TTP on 30-day mortality in Staphylococcus aureus bacteremia Staphylococcus aureus 16 Multiple Long TTP (>48 h) is associated with increased risk of mortality, and results support empiric antibiotic coverage beyond 48 h in patients at high risk of Staphylococcus aureus bacteremia
2019, Siméon S 31 Prospective France Adult (587) Determine the relationship between TTP and the risk of infective endocarditis or mortality Staphylococcus aureus 13.7 Infective endocarditis Short TTP is independently associated with infective endocarditis and mortality in patients with Staphylococcus aureus bacteremia and is at a higher risk for infective endocarditis
2020, Saksena R 10 Retrospective India Children (60) Determine the correlation between TTP and clinical outcome in bacteremia Staphylococcus aureus N/A Multiple Patients with TTP ≤16.5 h tend to get worse in clinical condition than those with longer TTP in terms of MV, sepsis, and mortality.
2006, Marra AR 11 Retrospective USA Adult (373) Determine the TTP of Staphylococcus aureus BSIs and its impact on clinical outcomes Staphylococcus aureus 12.2 Multiple TTP ≤12 h was observed in one half of the cases, and the risk of mortality increased with early TTP
2022, Bläckberg A 12 Retrospective Sweden Adult (286) Determine the correlation between TTP and 30-day mortality Streptococcus pyogenes 10.4 Multiple Median TTP was significantly shorter in patients who died within 30 d compared to surviving patients (8.6 vs 10.4 h; P < .001)
2001, Neuman MI 32 Retrospective USA Pediatric (175) Determine the TTP of Streptococcus pneumoniae BSIs and its impact on clinical outcomes Streptococcus pneumoniae 11.5 Multiple 90% of S. pneumoniae are detected within 14 h, and TTP cannot be used as a predictor for early vs late growth of the pathogen
2017, Cillóniz C 33 Prospective Spain Adult (278) Impact of TTP on clinical outcome and severity of infection Streptococcus pneumonia 10.5 Community-acquired pneumonia Early TTP is independently associated with increased risk of mechanical ventilation, hospital stay, in-hospital mortality, and 30-day mortality. TTP is a valuable predictor for diagnosis and prognosis in Streptococcus pneumonia community-acquired pneumonia
2017, Tang PC 1 Retrospective Taiwan Adult (139) Determine the correlation between TTP and clinical outcomes Pseudomonas aeruginosa 15 Multiple Short TTP (≤13 h) had a higher 30-day mortality rate than those with TTP >13 h (54.2% vs 15.0%, P < .001), severe sepsis (66.1% vs 35.0%, P < .001), and prolonged hospitalization (25.6 ± 48.5 d vs 16.3 ± 15.3 d, P < .16)
2013, Willmann M 13 Retrospective Germany Adult (83) Impact of TTP on mortality Pseudomonas aeruginosa 14.59 Multiple TTP ≤18 in Pseudomonas aeruginosa BSI is independently correlated with mortality
2018, Chen SY 34 Retrospective Taiwan Adult (206) Impact of TTP on patient outcome in nontyphoidal Salmonella bacteremia Salmonella 16.1 Multiple Short TTP <10 h is associated with severe outcome. TTP is important to provide diagnostic and prognostic data in nontyphoidal Salmonella bacteremia
2020, Kuzniewicz M 14 Retrospective USA Newborns (594) Determine TTP of neonatal BCs for early onset sepsis Polymicrobial 21 N/A Results of the study recommended an observation period of 36 h and considered de-escalation of empiric antibiotics.
2019, Pan F 4 Retrospective China, Shanghai Children (808) Determine the relationship between TTP and microbiological outcome and clinical value in BSI Polymicrobial 30.97 Primary BSI The TTP of Gram-negative strains was significantly shorter than that of Gram-positive strains (P < .001) and fungi (P = .032). TTP provides a useful utility as a prognostic index, and a predictor of bacteria and MDR
2022, Mukhopadhyay S 15 Retrospective USA Infants (3808) Determine TTP with late onset bacteremia and predictors of TTP >36 h Polymicrobial 23.5 Multiple Reduction in empiric antibiotics duration in late onset infections to 36 h (excluding CoNS) and 48 h when considering CoNS
2021, Huggard D 16 Retrospective Ireland Neonates (605) Determine the predictive value of TTP and evaluate 36 h rule to de-escalate empiric antibiotics Polymicrobial 12.4 Multiple Short TTP is an essential predictor of highly pathogenic organisms when suspecting sepsis. In addition, the study supports the 36-h rule to de-escalate empiric antibiotics.
2014, Pardo J 17 Retrospective USA (Florida) Adult (416) Prevalence of BSIs after 24 h and impact of prior antibiotics administration Polymicrobial 13.7 Multiple Most BSIs are detected within ≤48 h adjusting the empirical antibiotic is safe
2011 Guerti K 18 Retrospective Belgium Neonates (1828) Determine the TTP of BCs and differences between early and late onset sepsis. Polymicrobial 21.33 Multiple De-escalation of empiric antibiotics to solely cover gram-positive bacteria at 48 h, and support stopping antibiotics at 72 h when culture is still negative. The study didn’t support a 24-36 h observation period.
2014, Biondi EA 35 Retrospective USA Infants (329) Determine the TTP of BCs in febrile infants Polymicrobial 15.41 N/A Most pathogens are detected within 24 h of collection in febrile infants with bacteremia, and the results support an observation period of no more than 24 h
2021, Nadeem R 36 Retrospective UAE Adult (101) Impact of TTP on clinical outcome in the ICU Polymicrobial 20.2 Multiple TTP did not predict mortality and ICU stay
2017, Martín-Gutiérrez G 6 Prospective Spain Adult (332) Impact of TTP on clinical and microbiological outcome Polymicrobial 7.3 Multiple TTP can be used as a prognostic parameter and an independent predictor for mortality
2019, Lambregts MMC 19 Retrospective Netherlands Adult (801) Determine the probability of positivity after 24 h and the clinical predictor of TTP Polymicrobial 15.7 Multiple The positivity of BCs after 24 h is very low, and the results support clinical re-evaluation and de-escalation of antibiotics at 24 h
2020, Alpern ER 37 Prospective USA Infant (329) Determine the TTP of bacteria in BC and CSF in a febrile infant Polymicrobial BC BP:16.6 C:25.1 CSF BP:14 C:40.5 Multiple Most of the blood and CSF cultures were positive for bacterial pathogens within 24 h, and TTP for bacterial pathogens was significantly shorter than for contaminants
2021, Bae HJ 38 Retrospective Korea Adults (1012) Determine the correlation between TTP and 90-day mortality in septic shock Polymicrobial 9.5 Multiple Short TTP is correlated with severe infection and a higher SOFA score, but not with mortality.

Abbreviations: 1st TTP, first TTP detected in the first collected BC; 2nd TTP, the second TTP detected in the second collected BC; BCs, blood cultures; BP, bacterial pathogen; BSI, blood stream infection; C, contaminant; CoNS, coagulase-negative staphylococci; ICU, intensive care unit; MDR, multidrug resistant; MV, mechanical ventilation; SOFA, sequential organ failure assessment; TTP, time-to-positivity.

Bacterial species are listed in alphabetical order within each group, starting from gram-positive bacteria, then gram-negative bacteria, and finally polymicrobial.

Discussion

Early Antimicrobial Optimization

The preliminary signal of blood culture positivity provides vital information for antimicrobial stewardship and early optimization of antibiotics. A cohort study reported that 85.3% of blood cultures showed an initial growth with TTP within 24 hours. 19 These findings help clinicians reconsider early evaluation of empiric antimicrobial therapy. Gram staining is a crucial microbiological tool that promotes the early de-escalation of antimicrobial treatment, as results are typically accessible within 24 hours. For instance, intervention may include initiation of vancomycin or de-escalation based on results of gram-positive cocci in clusters, suggesting Staphylococcus aureus versus coagulase-negative Staphylococci. 20 A noninferiority randomized clinical trial in ventilator-associated pneumonia (VAP) found that gram stain-guided antibiotic initiation was noninferior to guideline-based empirical antibiotic initiation and significantly limited the use of empirical antibiotic initiation. 21 A meta-analysis supports the use of Gram staining in guiding the selection of the initial antibiotic, thereby reducing the use of broad-spectrum antibiotics without impairing clinical outcomes and coverage rates. 22

Discrepancies and Challenges Towards Implementation

TTP is a challenging indicator in routine practice and should be interpreted cautiously. Some cofactors can affect interpretation, including sampling (blood volume, type of sample, or collection time), culture conditions (broth media, atmosphere, and delay of sample transfer), prior antimicrobial therapy, types of microorganisms, and source of infection. Several previous studies support the theory that short TTP was associated with higher bacterial load in blood culture.5,6 Consequently, severe infection and mortality were adequately documented with short TTP. Significant discrepancies have been observed among reported cutoff values of different bacterial species and infection sites. Thus, using cutoff values from cohort studies of single-center experience would lead to a misleading interpretation.

The utility of TTP in differentiating sources of infection and distinguishing bacterial species has been investigated, resulting in discrepancies in TTP cut-off values. Accordingly, relying on these cut-offs in routine clinical practice needs to be prudent. In a prospective study, a significant difference between the anatomical source of infection and TTP in terms of clinical features of patients was observed, and the abdominal source of infection was significantly associated with delayed TTP. 6 In a retrospective review of Pseudomonas aeruginosa, TTP varied significantly among different infection sources. 1 Longer TTP was observed in urinary tract infection (UTI) than those without UTI (34.0 hours vs 17.6 hours, P < .001), and shorter TTP was observed with primary bacteremia than secondary bacteremia (15.7 hours vs 22.1 hours, P = .008). In Escherichia coli, UTI was correlated with a prolonged TTP (>7 hours), whereas pneumonia was associated with a short TTP (≤7 hours). 23 However, no correlation was observed between the TTP of Pseudomonas aeruginosa and infection sources in a retrospective review of Pseudomonas aeruginosa bloodstream infections. 6 Despite the implementation challenges and discrepancies in cut-off values of TTP in clinical practice, TTP continues to promote antimicrobial stewardship and early antibiotics optimization.

TTP and Antimicrobial Stewardship

Antimicrobial resistance is a significant global challenge to public health, driving widespread concern about the implementation of antimicrobial stewardship (AMS). Strategies of AMS emphasize judicious use of antimicrobials to optimize treatment outcomes and reduce antimicrobial resistance. Limiting the duration of antimicrobials to the optimal has been encouraged by AMS practitioners due to its significant implications on resistance, adverse events, and hospitalization. Guidelines recommended a de-escalation approach of broad-spectrum antimicrobials based upon culture results and clinical re-evaluation of patients. 7

A wide range of studies has demonstrated the exact timing of antimicrobial re-evaluation and de-escalation approaches, which depend on the results of blood cultures becoming available at around 48 to 72 hours.24,25 Moreover, the CDC recommends re-evaluation and time-out of antimicrobials after 48 hours. 26 However, several studies investigated TTP and concluded that the traditional observational period of empiric broad-spectrum antimicrobials (48-72 hours) could be reduced to 24 to 36 hours. 27 In a large retrospective observational study conducted at a quaternary care pediatric hospital, TTP of blood cultures was investigated, and the authors guaranteed a practice change to a short observational period of 36 hours in different clinical conditions, leading to a reduction in inappropriate antibiotic consumption and fewer adverse events. 27 Moreover, in a retrospective study on patients with febrile neutropenia (FN), bloodstream infections were analyzed and correlated with TTP, resulting in a TTP <24 hours in most bloodstream infections, including all episodes of multidrug-resistant gram-negative bacteria. 28 These results support the stewardship application of the de-escalation approach and re-evaluation of empiric broad-spectrum antibiotics at 24 hours, rather than 48 to 96 hours, as most blood cultures in FN are positive within the first 24 hours. The positivity of blood culture with TTP ≥24 hours typically occurs with contaminants, yeast infections, and anaerobic gram-negative bacteria.

Conclusion

TTP is a promising clinical parameter that can be used to guide clinical decisions and aid in the early re-evaluation of empiric antimicrobial therapy. However, the full implementation of TTP to distinguish the bacterial species and site of infection is premature due to significant timing discrepancies and insufficient evidence to guarantee practice change. This ambiguity confuses practitioners in routine practice. Thus, it is crucial to re-evaluate the clinical condition and outcome of empiric broad-spectrum antibiotics when the probability of bacteremia changes and weigh the potential costs and benefits of the de-escalation approach. Larger prospective studies are recommended in the future to investigate the clinical utility of TTP and its correlation with clinical and antimicrobial stewardship outcomes. Furthermore, additional studies are needed to investigate the effects of blood volume, prior antibiotic therapy, and sampling site on TTP, thereby enhancing diagnostic accuracy.

Ahmed S. Elnoby
Clinical Pharmacy Department, Ahl Masr Hospital, Cairo, Egypt
Radwa Nahla
Dornsife School of Public Health, Drexel University, Philadelphia, PA, USA

Footnotes

ORCID iD: Ahmed S. Elnoby Inline graphic https://orcid.org/0000-0002-8567-1326

References

  • 1. Tang PC, Lee CC, Li CW, Li MC, Ko WC, Lee NY. Time-to-positivity of blood culture: an independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia. J Microbiol Immunol Inf. 2017;50(4):486-493. [DOI] [PubMed] [Google Scholar]
  • 2. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Palmer HR, Palavecino EL, Johnson JW, Ohl CA, Williamson JC. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. Eur J Clin Microbiol Infect Dis. 2013;32(7):955-959. [DOI] [PubMed] [Google Scholar]
  • 4. Pan F, Zhao W, Zhang H. Value of time to positivity of blood culture in children with bloodstream infections. Can J Infect Dis Med Microbiol. 2019;1:5975837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Falconer K, Hammond R, Parcell BJ, Gillespie SH. Investigating the time to blood culture positivity: why does it take so long? J Med Microbiol. 2025;74(1):1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Martín-Gutiérrez G, Martín-Pérez C, Gutiérrez-Pizarraya A, Lepe JA, Cisneros JM, Aznar J. Time to positivity of blood cultures in patients with bloodstream infections: a useful prognostic tool. Enfermed Infect Microbiol Clin (Engl ed). 2017;35(10):638-644. [DOI] [PubMed] [Google Scholar]
  • 7. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-e77. doi: 10.1093/cid/ciw118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Baang JH, Inagaki K, Nagel J, et al. Inpatient Diagnosis and Treatment of Catheter-Related Bloodstream Infection. Ann Arbor, MI: Michigan Medicine University of Michigan; 2023. [PubMed] [Google Scholar]
  • 9. Oldberg K, Thorén R, Nilson B, Gilje P, Inghammar M, Rasmussen M. Short time to blood culture positivity in Enterococcus faecalis infective endocarditis. Eur J Clin Microbiol Infect Dis. 2021;40(8):1657-1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Saksena R, Singhal A, Gaind DR. Correlation between time-to-positivity of blood culture and clinical outcomes in Staphylococcus aureus bacteremia. Int J Infect Dis. 2020;101:122. [Google Scholar]
  • 11. Marra AR, Edmond MB, Forbes BA, Wenzel RP, Bearman GML. Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol. 2006;44(4):1342-1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Bläckberg A, Svedevall S, Lundberg K, Nilson B, Kahn F, Rasmussen M. Time to blood culture positivity: an independent predictor of mortality in Streptococcus pyogenes bacteremia. Open Forum Infect Dis. 2022;9(6):ofac163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Willmann M, Kuebart I, Vogel W, et al. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection. J Infect. 2013;67(5):416-423. [DOI] [PubMed] [Google Scholar]
  • 14. Kuzniewicz MW, Mukhopadhyay S, Li S, Walsh EM, Puopolo KM. Time to positivity of neonatal blood cultures for early-onset sepsis. Pediatr Infect Dis J. 2020;39(7):634-640. [DOI] [PubMed] [Google Scholar]
  • 15. Mukhopadhyay S, Briker SM, Flannery DD, et al. Time to positivity of blood cultures in neonatal late-onset bacteraemia. Arch Dis Child Fetal Neonatal Ed. 2022;107(6):583-588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Huggard D, Powell J, Kirkham C, Power L, O’Connell NH, Philip RK. Time to positivity (TTP) of neonatal blood cultures: a trend analysis over a decade from Ireland. J Matern Fetal Neonatal Med. 2021;34(5):780-786. [DOI] [PubMed] [Google Scholar]
  • 17. Pardo J, Klinker KP, Borgert SJ, Trikha G, Rand KH, Ramphal R. Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours. Ann Pharmacother. 2014;48(1):33-40. [DOI] [PubMed] [Google Scholar]
  • 18. Guerti K, Devos H, Ieven MM, Mahieu LM. Time to positivity of neonatal blood cultures: fast and furious? J Med Microbiol. 2011;60(Pt 4):446-453. [DOI] [PubMed] [Google Scholar]
  • 19. Lambregts MMC, Bernards AT, van der Beek MT, Visser LG, de Boer MG. Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy. PLoS One. 2019;14(1):e0208819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Turenne CY, Witwicki E, Hoban DJ, Karlowsky JA, Kabani AM. Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR–single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol. 2000;38(2):513-520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Yoshimura J, Yamakawa K, Ohta Y, et al. Effect of gram stain–guided initial antibiotic therapy on clinical response in patients with ventilator-associated pneumonia: the GRACE-VAP randomized clinical trial. JAMA Netw Open. 2022;5(4):e226136. doi: 10.1001/jamanetworkopen.2022.6136 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Ito H, Tomura Y, Oshida J, Fukui S, Kodama T, Kobayashi D. The role of gram stain in reducing broad-spectrum antibiotic use: a systematic literature review and meta-analysis. Infect Dis Now. 2023;53(6):104764. [DOI] [PubMed] [Google Scholar]
  • 23. Martínez JA, Soto S, Fabrega A, et al. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol. 2006;44(4):1468-1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Roger PM, Labate C, Serre S, et al. Factors associated with effective reassessment of antibiotic therapy on day 3. Med Mal Infect. 2013;43(3):123-127. [DOI] [PubMed] [Google Scholar]
  • 26. Pollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014;59(Suppl_3):S97-S100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. MacBrayne CE, Williams MC, Prinzi A, Pearce K, Lamb D, Parker SK. Time to blood culture positivity by pathogen and primary service. Hosp Pediatr. 2021;11(9):953-961. [DOI] [PubMed] [Google Scholar]
  • 28. Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, et al. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2019;25(4):447-453. [DOI] [PubMed] [Google Scholar]
  • 29. Hsu MS, Huang YT, Hsu HS, Liao CH. Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014;20(9):892-898. [DOI] [PubMed] [Google Scholar]
  • 30. Kim J, Gregson DB, Ross T, Laupland KB. Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality. J Infect. 2010;61(3):197-204. [DOI] [PubMed] [Google Scholar]
  • 31. Simeon S, Le Moing V, Tubiana S, Duval X, Fournier D, Lavigne JP, Erpelding ML, Gustave CA, Desage S, Chirouze C, Vandenesch F. Time to blood culture positivity: an independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2019;25(4):481-488. [DOI] [PubMed] [Google Scholar]
  • 32. Neuman MI, Harper MB. Time to positivity of blood cultures for children with Streptococcus pneumoniae bacteremia. Clin Infect Dis. 2001;33(8):1324-1328. [DOI] [PubMed] [Google Scholar]
  • 33. Cillóniz C, Ceccato A, De La Calle C, Gabarrús A, Garcia-Vidal C, Almela M, Soriano A, Martinez JA, Marco F, Vila J, Torres A. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia. PLoS One. 2017;12(8):e0182436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Chen SY, Weng TH, Tseng WP, Fu CM, Lin HW, Liao CH, Lee TF, Hsueh PR, Fang CC, Chen SY. Value of blood culture time to positivity in identifying complicated nontyphoidal Salmonella bacteremia. Diagn Microbiol Infect Dis. 2018;91(3):210-216. [DOI] [PubMed] [Google Scholar]
  • 35. Biondi EA, Mischler M, Jerardi KE, Statile AM, French J, Evans R, Lee V, Chen C, Asche C, Ren J, Shah SS. Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatr. 2014;168(9):844-849. [DOI] [PubMed] [Google Scholar]
  • 36. Nadeem R, Elhoufi AM, Salama L, Mahmoud M, Bon I, Kamat S, Elsousi A, Abdalla RM, Obaida ZA, Elzeiny M. Time to grow positive blood cultures and its impact on clinical outcomes in patients with bacteremia admitted to intensive care unit. Dubai Med J. 2021;4(1):47-52. [Google Scholar]
  • 37. Alpern ER, Kuppermann N, Blumberg S, Roosevelt G, Cruz AT, Nigrovic LE, Browne LR, VanBuren JM, Ramilo O, Mahajan P. Time to positive blood and cerebrospinal fluid cultures in febrile infants≤ 60 days of age. Hosp Pediatr. 2020;10(9):719-727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Bae HJ, Kim JS, Kim M, Kim YJ, Kim WY. Prognostic value of the time-to-positivity in blood cultures from septic shock patients with bacteremia receiving protocol-driven resuscitation bundle therapy: a retrospective cohort study. Antibiotics. 2021;10(6):683. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Hospital Pharmacy are provided here courtesy of SAGE Publications

RESOURCES